Webinar Five
FIVE Webinar Five focuses on Age-related Macular Degeneration (AMD), [...]
Eleva Appoints Donato Spota as Chief Financial Officer
Eleva Appoints Donato Spota as Chief Financial Officer [...]
Eleva publishes evidence in preclinical dry AMD study
Eleva publishes evidence of immunomodulation and neuroprotection using its Factor [...]
Eleva Appoints Martin Bauer, MD as Chief Medical Officer
Eleva Appoints Martin Bauer, MD as Chief Medical Officer Adding [...]
Eleva and 3PBIOVIAN sign strategic alliance
Eleva and 3PBIOVIAN sign strategic GMP manufacturing and technology alliance [...]
Euro Health Leaders features Eleva and CEO Björn Cochlovius
Euro Health Leaders features Eleva and CEO Björn Cochlovius [...]
Eleva Receives Orphan Drug Designation in Europe for Proprietary Factor H Therapy in C3 Glomerulopathy (C3G)
Eleva receives Orphan Drug Designation in Europe for proprietary [...]
